Dr. Imadul Islam
Dr. Imadul Islam has more than 20 years of experience in discovery and development of new chemical entity (NCE) and management of drug discovery programs at major pharmaceutical companies. Dr. Imad is currently employed as Senior Research Scientist by National Guard Health Affairs at King Abdullah International Medical Research Center (KAIMRC), in Riyadh, Kingdom of Saudi Arabia. Prior to joining KAIMRC, Dr. Imad was director of CNS preclinical drug discovery at Bristol Myers Squibb ( BBRC) in Bangalore, India. Prior to BBRC, Dr. Imad held position at Glaxo Smith Kline, Singapore, as an investigator in CNS preclinical drug discovery. Dr. Imad held position of escalating responsibilities at Berlex Biosciences (Bayer/Schering) USA in the drug discovery group and was involved in preclinical and clinical research in oncology, immunology/ inflammation, and cardiovascular therapeutic areas. Dr. Imad was scientist at Synaptic Pharmaceutical (Lundbeck), USA working in the area of metabolic diseases like obesity. Dr. Imad was associate research scientist at Arizona State University, USA and Upjohn Pharmaceuticals (Pfizer) Kalamazoo, USA. To his credit, Dr. Imad has 27 issued US patents and 35 peer reviewed publications and several preclinical and clinical candidates.